01 Jan Lipid profiles for nevirapine vs. atazanavir/ritonavir, both combined with tenofovir disoproxil fumarate and emtricitabine over 48 weeks, in treatment-naïve HIV-1-infected patients (the ARTEN study)
Posted at 00:00h
in
Authored by: Podzamczer Daniel, Andrade-Villanueva J., Clotet B., Taylor S., Rockstroh J. K., Reiss P., Domingo P., Gellermann H. J., de Rossi L., Cairns V., Soriano V.
In: HIV MEDICINE 12(6), 2011, p.374-382
http://www.ncbi.nlm.nih.gov/pubmed/21518220